The association between hepatitis B virus infection and disease activity, synovitis, or joint destruction in rheumatoid arthritis

Clinical Rheumatology

Volumn 32, Issue 6, 2013, Pages 787-795

  Zou, Chan Juan ^a   Zhu, Lang Jing ^a   Li, Yan Hua ^a   Mo, Ying Qian ^a   Zheng, Dong Hui ^a   Ma, Jian Da ^a   Ou Yang, Xia ^a   Pessler, Frank ^b   Dai, Lie ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Disease activity; Hepatitis B virus; Joint destruction; Rheumatoid arthritis; Synovitis

Indexed keywords

ALANINE AMINOTRANSFERASE; C REACTIVE PROTEIN; CD20 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD68 ANTIGEN; CD79A ANTIGEN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN; HERBACEOUS AGENT; HYDROXYCHLOROQUINE; LEFLUNOMIDE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ADOLESCENT; ADULT; AGED; ARTHRALGIA; ARTICLE; CD3+ T LYMPHOCYTE; CELL DENSITY; CHILD; CHINESE; CLINICAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HAND RADIOGRAPHY; HEPATITIS B; HUMAN; IMMUNOHISTOCHEMISTRY; JOINT DESTRUCTION; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; POPULATION; PREVALENCE; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SCHOOL CHILD; SYNOVITIS; TISSUE SECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ARTHRITIS, RHEUMATOID; CHILD; CHINA; COMORBIDITY; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOHISTOCHEMISTRY; JOINT DISEASES; MALE; MIDDLE AGED; SYNOVITIS; YOUNG ADULT;

EID: 84879206170     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-013-2170-1     Document Type: Article

References (45)

1. McInnes IB, Schett G (2011) The pathogenesis of rheumatoid arthritis. N Engl J Med 365:2205-2219
2. Auger I, Roudier J (1997) A function for the QKRAA amino acid motif: mediating binding of DnaJ to DnaK. Implications for the association of rheumatoid arthritis with HLA-DR4. J Clin Invest 99:1818-1822
3. Kamphuis S, Kuis W, de Jager W, Teklenburg G, Massa M, Gordon G et al (2005) Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis. Lancet 366:50-56
4. Wegner N, Wait R, Sroka A, Eick S, Nguyen KA, Lundberg K et al (2010) Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and alpha-enolase: implications for autoimmunity in rheumatoid arthritis. Arthritis Rheum 62:2662-2672
5. Ganem D, Prince AM (2004) Hepatitis B virus infection - natural history and clinical consequences. N Engl J Med 350:1118-1129
6. Lok AS, McMahon BJ (2007) Chronic hepatitis B. Hepatology 45:507-539
7. Liang X, Bi S, Yang W, Wang L, Cui G, Cui F et al (2009) Epidemiological serosurvey of hepatitis B in China - declining HBV prevalence due to hepatitis B vaccination. Vaccine 27:6550-6557
8. Han SH (2004) Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 8:403-418
9. Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B et al (1999) Rheumatic disorders developed after hepatitis B vaccination. Rheumatology (Oxford) 38:978-983
10. Csepregi A, Rojkovich B, Nemesanszky E, Poor G, Hejjas M, Horanyi M (2000) Chronic seropositive polyarthritis associated with hepatitis B virus-induced chronic liver disease: a sequel of virus persistence. Arthritis Rheum 43:232-233
11. Scully LJ, Karayiannis P, Thomas HC (1992) Interferon therapy is effective in treatment of hepatitis B-induced polyarthritis. Dig Dis Sci 37:1757-1760
12. Permin H, Aldershvile J, Nielsen JO (1982) Hepatitis B virus infection in patients with rheumatic diseases. Ann Rheum Dis 41:479-482
13. Lim MK, Sheen DH, Lee YJ, Mun YR, Park M, Shim SC (2009) Anti-cyclic citrullinated peptide antibodies distinguish hepatitis B virus (HBV)-associated arthropathy from concomitant rheumatoid arthritis in patients with chronic HBV infection. J Rheumatol 36:712-716
14. Csepregi A, Nemesanszky E, Rojkovich B, Poor G (2001) Rheumatoid arthritis and hepatitis B virus: evaluating the pathogenic link. J Rheumatol 28:474-477
15. Maya R, Gershwin ME, Shoenfeld Y (2008) Hepatitis B virus (HBV) and autoimmune disease. Clin Rev Allergy Immunol 34:85-102
16. Ram M, Anaya JM, Barzilai O, Izhaky D, Porat KB, Blank M et al (2008) The putative protective role of hepatitis B virus (HBV) infection from autoimmune disorders. Autoimmun Rev 7:621-625
17. Vassilopoulos D, Calabrese LH (2008) Virally associated arthritis 2008: clinical, epidemiologic, and pathophysiologic considerations. Arthritis Res Ther 10:215
18. Momohara S, Okamoto H, Tokita N, Tomatsu T, Kamatani N (2006) Rapidly destructive knee arthropathy associated with hepatitis B. Clin Exp Rheumatol 24:111-112
19. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324
20. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CR et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569-2581
21. Smolen JS, Breedveld FC, Schiff MH, Kalden JR, Emery P, Eberl G et al (2003) A simplified disease activity index for rheumatoid arthritis for use in clinical practice. Rheumatology (Oxford) 42:244-257
22. Aletaha D, Smolen JS (2006) The definition and measurement of disease modification in inflammatory rheumatic diseases. Rheum Dis Clin N Am 32:9-44
23. Fransen J, Creemers MC, Van Riel PL (2004) Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 43:1252-1255
24. van der Heijde D (2000) How to read radiographs according to the Sharp/van der Heijde method. J Rheumatol 27:261-263
25. Dienstag JL (2008) Hepatitis B virus infection. N Engl J Med 359:1486-1500
26. Hoofnagle JH (2009) Reactivation of hepatitis B. Hepatology 49:S156-S165
27. Schumacher HJ, Kulka JP (1972) Needle biopsy of the synovial membrane - experience with the Parker-Pearson technic. N Engl J Med 286:416-419
28. Gerlag D, Tak PP (2005) Synovial biopsy. Best Pract Res Clin Rheumatol 19:387-400
29. Krenn V, Morawietz L, Burmester GR, Kinne RW, Mueller-Ladner U, Muller B et al (2006) Synovitis score: discrimination between chronic low-grade and high-grade synovitis. Histopathology 49:358-364
30. Nanashima A, Nakayama T, Sumida Y, Abo T, Takeshita H, Shibata K et al (2008) Relationship between microvessel count and post-hepatectomy survival in patients with hepatocellular carcinoma. World J Gastroenterol 14:4915-4922
31. Bresnihan B, Cunnane G, Youssef P, Yanni G, Fitzgerald O, Mulherin D (1998) Microscopic measurement of synovial membrane inflammation in rheumatoid arthritis: proposals for the evaluation of tissue samples by quantitative analysis. Br J Rheumatol 37:636-642
32. Youssef PP, Smeets TJ, Bresnihan B, Cunnane G, Fitzgerald O, Breedveld F et al (1998) Microscopic measurement of cellular infiltration in the rheumatoid arthritis synovial membrane: a comparison of semiquantitative and quantitative analysis. Br J Rheumatol 37:1003-1007
33. Wang Q, Chen YS, Wang XJ, Wang WJ, Wang YL, Liang XF (2007) Investigation and study of the prevalence of chronic hepatitis B and C. Modern Preventive Medicine 21:4005-4006
34. Kim DA, Kim TY (2010) Is screening for hepatitis necessary in diagnostic evaluation of rheumatoid arthritis in South Korea? J Rheumatol 37(674-675):675
35. Gabriel SE (2001) The epidemiology of rheumatoid arthritis. Rheum Dis Clin N Am 27:269-281
36. Zeng QY, Chen R, Darmawan J, Xiao ZY, Chen SB, Wigley R et al (2008) Rheumatic diseases in China. Arthritis Res Ther 10:R17
37. Chung SJ, Kim JK, Park MC, Park YB, Lee SK (2009) Reactivation of hepatitis B viral infection in inactive HBsAg carriers following anti-tumor necrosis factor-alpha therapy. J Rheumatol 36:2416-2420
38. Thong BY, Koh ET, Chng HH, Chow WC (2007) Outcomes of chronic hepatitis B infection in Oriental patients with rheumatic diseases. Ann Acad Med Singap 36:100-105
39. Pijak M, Gazdik F (2002) Negative association between rheumatoid arthritis and both hepatitis B infection and rHBsAg vaccination. Hepatology 36:2208
40. Pope JE, Stevens A, Howson W, Bell DA (1998) The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol 25:1687-1693
41. Rulli NE, Melton J, Wilmes A, Ewart G, Mahalingam S (2007) The molecular and cellular aspects of arthritis due to alphavirus infections: lesson learned from Ross River virus. Ann N Y Acad Sci 1102:96-108
42. Posnett DN, Yarilin D (2005) Amplification of autoimmune disease by infection. Arthritis Res Ther 7:74-84
43. Schumacher HR, Gall EP (1974) Arthritis in acute hepatitis and chronic active hepatitis. Pathology of the synovial membrane with evidence for the presence of Australia antigen in synovial membranes. Am J Med 57:655-664
44. Liaw YF (2009) Natural history of chronic hepatitis B virus infection and long-term outcome under treatment. Liver Int 29(Suppl 1):100-107
45. Chisari FV, Isogawa M, Wieland SF (2010) Pathogenesis of hepatitis B virus infection. Pathol Biol (Paris) 58:258-266